Systems and methods for non-invasive determination of covid-19 coronavirus infection
AssigneeTerahertz Group Ltd.
InventorsEran GABBAI, Yaniv MAYDAR, Regina AHARONOV-NADBORNY
Life of this patent
Estimating the term…
Loading patent…
AssigneeTerahertz Group Ltd.
InventorsEran GABBAI, Yaniv MAYDAR, Regina AHARONOV-NADBORNY
Estimating the term…
A high throughput method for label-free, noncontact, noninvasive, and nondestructive detection of at least one virus infected or virus free individual from at least one tested individual is provided. The method includes collecting a sample from exhaled breath of a subject for analysis of the sample. The collecting includes the subject exhaling into at least one sampler and collecting aerosols and/or any airborne compound from the exhaled breath by passing the exhaled breath through a metamaterial membrane within the sampler. The metamaterial membrane is arranged transverse to a flow of exhaled breath through the sampler. The method further includes analyzing the sample for detection of at least one virus infected individual from at least one tested individual.
-860. (canceled)
A high throughput system for label-free, noncontact, noninvasive, and nondestructive detection of at least one virus infected or virus free individual from at least one tested individual, the system comprising:
A high throughput method for label-free, noncontact, noninvasive, and nondestructive detection of at least one virus infected or virus free individual from at least one tested individual, the method comprising:
A sampler to be integrated into a system for label-free, noncontact, noninvasive, and nondestructive detection of at least one virus infected or virus free individuals from at least one tested individual, the sampler comprising:
Dependencies are inferred from the claim text.